These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 6876429

  • 1. [Current status of interferon therapy on malignant brain tumor].
    Nagai M, Arai T, Kohno S, Iizuka E.
    Gan No Rinsho; 1983 May; 29(6):608-15. PubMed ID: 6876429
    [Abstract] [Full Text] [Related]

  • 2. [Clinical effect of human fibroblast interferon (BM532) on malignant brain tumors--with special reference to gliomas].
    Nagai M.
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar 20; 24(3):638-46. PubMed ID: 2671205
    [Abstract] [Full Text] [Related]

  • 3. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O, Teramoto A, Yamamoto H, Ochiai C, Takakura K, Maruo K, Ueyama Y, Shimamura K.
    No To Shinkei; 1983 Sep 20; 35(9):905-11. PubMed ID: 6651989
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
    Shitara N, Nakamura H, Genka S, Takakura K.
    Gan To Kagaku Ryoho; 1987 Dec 20; 14(12):3235-44. PubMed ID: 3318704
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr 20; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

  • 6. [Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors].
    Yoshida J, Wakabayashi T, Kato K, Enomoto H, Kito A, Kageyama N.
    Gan To Kagaku Ryoho; 1986 Mar 20; 13(3 Pt 1):520-4. PubMed ID: 3456740
    [Abstract] [Full Text] [Related]

  • 7. [Local chemotherapy of cancer. Intrathecal administration].
    Nagai M.
    Gan To Kagaku Ryoho; 1989 Feb 20; 16(2):156-64. PubMed ID: 2465738
    [Abstract] [Full Text] [Related]

  • 8. [Postoperative treatment for malignant intracranial tumors--especially concerning intermittent intra-carotid administration of adriamycin].
    Sakai N, Kondo H, Shikinami A, Hirata T, Funakoshi T, Tanabe Y, Yamada H.
    No Shinkei Geka; 1984 Mar 20; 12(3 Suppl):237-43. PubMed ID: 6462330
    [Abstract] [Full Text] [Related]

  • 9. Clinical effect of interferon in malignant brain tumours.
    Nagai M, Arai T.
    Neurosurg Rev; 1984 Mar 20; 7(1):55-64. PubMed ID: 6379511
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y, Konishi T, Suzui H, Kamijo Y, Kang Y, Okumura T, Kaneko T, Kikuchi H.
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct 20; 24(10):2411-7. PubMed ID: 2614179
    [Abstract] [Full Text] [Related]

  • 11. [Clinical experience with alpha and beta interferon in childhood cancer].
    Ise T, Ohira M, Takayama J, Hanada M, Muchi H, Fukuma H, Beppu Y, Nomura K.
    Gan To Kagaku Ryoho; 1984 Sep 20; 11(9):1855-62. PubMed ID: 6591860
    [Abstract] [Full Text] [Related]

  • 12. Local application of interferon to malignant brain tumors.
    Nagai M, Arai T, Kohno S, Kohase M.
    Tex Rep Biol Med; 1984 Sep 20; 41():693-8. PubMed ID: 7052705
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.
    Olson JJ, James CD, Lawson D, Hunter S, Tang G, Billingsley J.
    Int J Oncol; 2004 Aug 20; 25(2):419-27. PubMed ID: 15254740
    [Abstract] [Full Text] [Related]

  • 14. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.
    Wakabayashi T, Natsume A, Hashizume Y, Fujii M, Mizuno M, Yoshida J.
    J Gene Med; 2008 Apr 20; 10(4):329-39. PubMed ID: 18220319
    [Abstract] [Full Text] [Related]

  • 15. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep 20; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

  • 16. [Antitumor efficacy of recombinant interferon-beta on human glioma].
    Miyao Y, Shimizu K, Okamoto Y, Matsui Y, Tsuda N, Yamada M, Tamura K, Mogami H.
    Gan To Kagaku Ryoho; 1987 Feb 20; 14(2):490-4. PubMed ID: 3813577
    [Abstract] [Full Text] [Related]

  • 17. [Advances of BRM therapy of malignant brain tumors].
    Nagai M.
    Gan To Kagaku Ryoho; 1991 Feb 20; 18(2):188-94. PubMed ID: 1992912
    [Abstract] [Full Text] [Related]

  • 18. [Study on human lymphoblastoid interferon-alpha (MOR-22): Part III. Antitumor effect on nude mouse-transplanted human tumors].
    Nobuhara M, Kanamori T, Harada Y, Horisawa Y, Ishii K, Yanagihara Y, Kiyonaga J.
    Gan To Kagaku Ryoho; 1986 Jan 20; 13(1):134-8. PubMed ID: 3753641
    [Abstract] [Full Text] [Related]

  • 19. [Interferon therapy for brain tumor patients (author's transl)].
    Ueda S, Hirakawa K, Suzuki K, Nakagawa Y, Ibayashi N, Kishida T.
    No Shinkei Geka; 1982 Feb 10; 10(2):149-54. PubMed ID: 6174892
    [Abstract] [Full Text] [Related]

  • 20. Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas.
    Tsuboi K, Saijo K, Ishikawa E, Tsurushima H, Takano S, Morishita Y, Ohno T.
    Clin Cancer Res; 2003 Aug 15; 9(9):3294-302. PubMed ID: 12960115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.